Skip to content

Economic Evaluation in Acupuncture: Past and Future

Jabbour et al. · The American Acupuncturist · 2009

📊Narrative Review🔍Analysis of 23 studies💰Strong Economic Evidence

Evidence Level

STRONG
85/ 100
Quality
4/5
Sample
4/5
Replication
5/5
🎯

OBJECTIVE

To review and analyze economic evaluation studies of acupuncture since the 1990s

👥

WHO

Analysis of 23 economic studies on acupuncture for various conditions

⏱️

PERIOD

Review of studies from 1995-2009

📍

CONDITIONS

Low back pain, headache, arthritis, angina, carpal tunnel syndrome

🔬 Study Design

32000participants
randomization

Cost-identification studies

n=2

basic cost analysis

Cost-effectiveness analyses

n=10

cost-clinical outcome comparison

Cost-utility analyses

n=8

analysis with QALYs

Cost-benefit analyses

n=3

direct monetary comparison

⏱️ Duration: Follow-up of 3 months to 5 years across analyzed studies

📊 Results in numbers

EUR 30,000

Average savings per angina patient

EUR 10,526

Cost per QALY in low back pain

0%

Rate of significant improvement

22 days

Reduction in headache days per year

EUR 11,657

Cost per QALY in headache

Percentage highlights

80%
Rate of significant improvement

📊 Outcome Comparison

Cost per QALY (in Euros)

Dysmenorrhea
3011
Low back pain
10526
Headache
11657
Neck pain
12469
💬 What does this mean for you?

This review shows that acupuncture is not only effective for treating various conditions but also offers good value for money. The studies demonstrate that, although acupuncture may cost slightly more up front, it saves money by reducing the need for medications, surgery, and physician visits. For patients, this means access to a safe, effective treatment that can be economically advantageous for the healthcare system.

📝

Article summary

Plain-language narrative summary

This comprehensive narrative review, conducted by Jabbour and colleagues, systematically examines the economic evidence on acupuncture accumulated over two decades, providing a critical analysis of 23 economic evaluation studies published between 1995 and 2009. The work emerges in a context of growing need for economic justification for all medical interventions, including complementary and alternative therapies, especially as pharmaceutical costs begin to exceed overall medical costs in health systems. The authors identified a significant evolution in the quality and sophistication of economic studies in acupuncture, moving from simple cost-identification analyses to complex cost-utility evaluations using standardized metrics such as quality-adjusted life years (QALYs). The methodology employed included systematic searches in Medline, PubMed, and Web of Science databases, using terms such as complementary alternative medicine, acupuncture, cost-effectiveness, and economics.

The analyzed studies covered a wide range of clinical conditions, including chronic low back pain, headache and migraine, arthritis, angina pectoris, carpal tunnel syndrome, allergic rhinitis, and dysmenorrhea. The results consistently demonstrated that acupuncture offers favorable cost-effectiveness compared with conventional care. For example, in low back pain patients, the incremental cost-effectiveness ratio was EUR 10,526 per QALY gained, well below the EUR 30,000 threshold considered acceptable in the United Kingdom. For chronic headache, the cost was EUR 11,657 per QALY, and for dysmenorrhea, only EUR 3,011 per QALY.

Studies on angina showed impressive savings of up to EUR 30,000 per patient over five years, primarily due to reduced hospitalizations and surgeries. The analysis revealed that, although the direct costs of acupuncture may be slightly higher than those of conventional care up front, indirect savings through reduced medication use, fewer physician visits, fewer sick days, and lower need for surgical interventions result in overall economic benefit. Spira's military study demonstrated savings of USD 3,956 per hospital day avoided, illustrating the potential of acupuncture in operational care settings. The authors emphasized that acupuncture proved particularly effective in conditions where conventional medicine has significant limitations or substantial side effects.

The review also identified gender differences in cost-effectiveness, with women often demonstrating better economic outcomes than men in conditions such as allergic rhinitis and osteoarthritis. The clinical implications are substantial, suggesting that integrating acupuncture into health systems can provide significant economic benefits while maintaining or improving health outcomes. The authors argue that countries such as Germany, which have incorporated acupuncture into their national health systems based on robust economic evidence, serve as models for other nations. The growing trend of reimbursement by insurers and national health systems reflects recognition of the favorable economic evidence on acupuncture.

Strengths

  • 1First comprehensive review of economic evidence in acupuncture
  • 2Analysis of multiple clinical conditions demonstrating consistency
  • 3Inclusion of studies with rigorous economic methodologies
  • 4Evidence from different international health systems
⚠️

Limitations

  • 1Significant variation in methodological quality across studies
  • 2Different payer perspectives make comparisons difficult
  • 3Limitations inherent to acupuncture research (blinding)
  • 4Lack of standardization in economic terminology
Dr. Marcus Yu Bin Pai

Expert Commentary

Dr. Marcus Yu Bin Pai

MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture

Clinical Relevance

Economic evaluation is often the most overlooked argument among physicians who prescribe acupuncture, and this review fills that gap directly. In public and private pain services, the pressure for cost justification is real and growing. The cost-per-QALY data for low back pain (EUR 10,526) and chronic headache (EUR 11,657) sit comfortably below the acceptability thresholds adopted by systems such as the British NHS, providing concrete arguments for the inclusion of acupuncture in institutional protocols. For angina, the savings of EUR 30,000 per patient over five years, via reduced hospitalizations, is a figure any health manager recognizes. The breadth of conditions covered — low back pain, headache, arthritis, dysmenorrhea, allergic rhinitis — reflects the real demand profile in rehabilitation and pain clinics, making this review directly applicable to decision-making about therapeutic incorporation.

Notable Findings

The gender difference in cost-effectiveness merits attention: women showed better economic outcomes than men in conditions such as allergic rhinitis and osteoarthritis, opening the way for patient stratification in practice. The savings observed for dysmenorrhea were only EUR 3,011 per QALY — the lowest cost per quality-adjusted outcome in the review — suggesting that this is, proportionally, one of the indications with the best value-for-money ratio in acupuncture. The finding that indirect costs (sick days lost, medication use, avoided consultations) are the major drivers of overall economic benefit is mechanistically coherent and clinically familiar. Spira's military data, with USD 3,956 in savings per hospital day avoided, demonstrate that the effect holds even in high-complexity care scenarios and in systems organizationally distinct from European ones.

From My Experience

In my practice in the musculoskeletal pain clinic, the discussion of cost-effectiveness inevitably arises when the patient asks whether their plan covers acupuncture, or when the team questions including the technique in the protocol. Having QALY data and consolidated savings figures from a review greatly facilitates that institutional conversation. I have observed that patients with chronic low back pain who combine acupuncture with a supervised exercise program significantly reduce their consumption of analgesics and anti-inflammatories within the first four to six sessions — which translates directly into cost savings these data capture well. For chronic headache, I usually plan cycles of eight to twelve initial sessions, with monthly maintenance in responders, and the reduction of 22 headache days per year described in the included studies is consistent with what I see. The profile that responds best economically — and clinically — tends to be the patient with high prior healthcare utilization, multiple emergency visits, and escalating analgesic regimens without satisfactory response.

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture.

Indexed scientific article

This study is indexed in an international scientific database. Check your institutional access to obtain the full article.

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.